Dr. Jeffrey Rothstein, MD

Dr. Rothstein practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Rothstein's NPI, 1568497907, was assigned on July 12, 2006. Dr. Rothstein graduated from Illinois Medical College in 1985. Dr. Rothstein holds Maryland license D38291.

Dr. Rothstein's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Rothstein's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Rothstein is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Rothstein to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rothstein practices. Vendor and product names are available with a free account.

Neurology is Dr. Rothstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rothstein is licensed in Maryland.

CMS data shows 61 Medicare services from Dr. Rothstein across 3 procedure codes in 2024, for 71 Medicare patients. Medicare paid $4,389 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 71 Medicare patients who saw Dr. Rothstein in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rothstein's median patient age at 68, with 42% women.

In 2024, Dr. Rothstein wrote 64 Medicare Part D claims for 25 patients. 94% of them were for generic drugs. CMS names the drug for 54 of them, across 2 drugs with 11 or more claims each, at $8,161 in total drug cost. In 2023, CMS named 53 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rothstein for performance year 2024, reported as part of a group.

Dmand AI links 139 papers to Dr. Rothstein, published from 2010 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Amyotrophic Lateral Sclerosis, C9orf72 Protein and Astrocytes. Dr. Rothstein has published most often in Neuron. Dr. Rothstein's most frequent co-authors are Jonathan D. Glass, MD, Merit Ester Cudkowicz, MD and Brett Michael Morrison, MD, PhD.

Dmand AI links Dr. Rothstein to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Amyotrophic Lateral Sclerosis, COVID-19 and Pneumonia, Viral. Open Payments lists research payments to Dr. Rothstein that name 1 trial.

CMS Open Payments shows 55 general payments to Dr. Rothstein from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Sanofi and Genzyme US Companies paid the most, $11,599. It also lists 27 research payments totaling $3,470 from 2017 to 2024, naming 1 clinical trial.

Dr. Rothstein graduated from Illinois Medical College in 1985.